Company / Cash per Share
Processa Pharmaceuticals, Inc. Cash per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.41
FY2022
5-year range
$0.00 / $1.16
FY2018-FY2022
Trend
-64.4%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.00 to $0.41 over the past 6 years.
Based on SEC 10-K filings.
0.41 in FY2022.
Improved from $0.00 to $0.41 over the past 6 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, cash per share decreased 64.4% year-over-year.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.41 | -64.4% |
| FY2021 | $1.16 | +395837.7% |
| FY2016 | $0.00 | +54.0% |
| FY2015 | $0.00 | -99.2% |
| FY2014 | $0.02 | -95.8% |
| FY2013 | $0.55 | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026